• Press Release

BIA response to UK government’s plans for free trade deals and tariff plans

Steve Bates OBE, Chief Executive of the BioIndustry Association said: “For the UK life sciences sector to understand the benefit of any free trade deal we need to see the granular detail of what the UK hopes to achieve. Strengthening Intellectual Property regimes globally would benefit innovative UK life sciences businesses, so it is positive to see the Government recognises the importance of this issue in planning a US FTA.”

BIA welcomes publication of the Life Sciences 2030 Skills Strategy

The UK BioIndustry Association (BIA) has welcomed today’s publication of the Life Sciences 2030 Skills Strategy. The report is a key deliverable from the Life Sciences Sector Deal 2 and sets out how the UK Life Sciences sector will attract, retain, train and develop the research, manufacturing and technical skills required by a dynamic and diverse UK sector.

UK biotech records third highest year for investment despite global uncertainty

New figures published today (Wednesday 22 January 2020) by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveal that the UK biotech sector raised £1.3 billion in 2019. The total is the third highest year recorded by the trade association and since 2012 investment has increased by over 400%

BIA responds to the newly announced NHS England/Novartis deal

Commenting on the new NHS England/Novartis deal and the publication of the new UK life sciences sector update announced at JP Morgan today, Steve Bates OBE, Chief Executive of the BioIndustry Association said: "Global players are announcing the UK as their destination of choice for innovation at this year’s JP Morgan Healthcare conference.

Helping BIA members to go global in 2020

The BIA will be attending a number of international conferences and events in 2020, where we will be developing closer ties with partners and promoting the strengths of the UK life sciences and biotech cluster to an international audience.

BIA reaction to the 2019 general election result

Steve Bates OBE, Chief Executive of the BIA said “A Conservative majority offers a new era of political stability at Westminster, which makes long term business decision making simpler for our sector. 

The BioIndustry Association announces 2020 charity partnership with Versus Arthritis

The BioIndustry Association (BIA) is proud to be working with Versus Arthritis as its charity partner for 2020.

Sharon Grimster (ReNeuron) and Sarah Goulding (Knowledge Transfer Network) to be recognised at bioProcessUK conference

Sharon Grimster of ReNeuron and Dr Sarah Goulding of the Knowledge Transfer Network (KTN) will be awarded the prestigious Peter Dunnill award and Richard Wilson impact award respectively, at the UK BioIndustry Association’s (BIA) 16th bioProcessUK conference in Liverpool later this month.

BIA launches biotech manifesto

The United Kingdom (UK) will have a general election on Thursday, 12 December. The UK BioIndustry Association (BIA) has today launched a biotech manifesto with its recommendations on how political parties can support the innovative UK life sciences sector.

BIA responds to the Smith - Reid Review on international research partnerships

Steve Bates OBE, Chief Executive of the BioIndustry Association (BIA) said: “Thanks to new advances in science and innovation, we are at the cusp of a new industrial revolution, however Brexit is causing much uncertainty for UK SMEs. I welcome the publication of this important review and it is good to see the Science Minister recognising the valuable contribution the life sciences sector makes in discovering new cures for life-threatening diseases.